118 related articles for article (PubMed ID: 11948476)
1. Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer families.
Ho GY; Knapp M; Freije D; Nelson WG; Smith JR; Carpten JD; Bailey-Wilson JE; Beaty TH; Petersen G; Xu J; Kamensky V; Walsh PC; Isaacs WB
Int J Cancer; 2002 Apr; 98(6):938-42. PubMed ID: 11948476
[TBL] [Abstract][Full Text] [Related]
2. ATAAA repeat upstream of glutathione S-transferase P1 and prostate cancer risk.
Platz EA; Krithivas K; Kantoff PW; Stampfer MJ; Giovannucci E
Urology; 2002 Jan; 59(1):159-64. PubMed ID: 11796315
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
4. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.
Irvine RA; Yu MC; Ross RK; Coetzee GA
Cancer Res; 1995 May; 55(9):1937-40. PubMed ID: 7728763
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients.
Harris MJ; Coggan M; Langton L; Wilson SR; Board PG
Pharmacogenetics; 1998 Feb; 8(1):27-31. PubMed ID: 9511178
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.
Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Hum Genet; 2002 Feb; 110(2):122-9. PubMed ID: 11935317
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.
Srivastava DS; Mandhani A; Mittal B; Mittal RD
BJU Int; 2005 Jan; 95(1):170-3. PubMed ID: 15638917
[TBL] [Abstract][Full Text] [Related]
8. Altered methylation of multiple genes in carcinogenesis of the prostate.
Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk.
Gsur A; Haidinger G; Hinteregger S; Bernhofer G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
Int J Cancer; 2001 May; 95(3):152-5. PubMed ID: 11307147
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population.
Nakazato H; Suzuki K; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Ito K; Kurokawa K; Yamanaka H
Anticancer Res; 2003; 23(3C):2897-902. PubMed ID: 12926131
[TBL] [Abstract][Full Text] [Related]
11. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490
[TBL] [Abstract][Full Text] [Related]
12. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of GSTP1 and related genes and prostate cancer risk.
Beer TM; Evans AJ; Hough KM; Lowe BA; McWilliams JE; Henner WD
Prostate Cancer Prostatic Dis; 2002; 5(1):22-7. PubMed ID: 15195126
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
15. Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American population.
Gilbert SM; Benson MC; McKiernan JM
Curr Urol Rep; 2002 Jun; 3(3):189-93. PubMed ID: 12084187
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
[TBL] [Abstract][Full Text] [Related]
17. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action.
Ding D; Xu L; Menon M; Reddy GP; Barrack ER
Prostate; 2005 Feb; 62(2):133-9. PubMed ID: 15389799
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
19. Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer.
Debes JD; Yokomizo A; McDonnell SK; Hebbring SJ; Christensen GB; Cunningham JM; Jacobsen SJ; Tindall DJ; Liu W; Schaid DJ; Thibodeau SN
Cancer Genet Cytogenet; 2004 Nov; 155(1):82-6. PubMed ID: 15527908
[TBL] [Abstract][Full Text] [Related]
20. Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene.
Dietzsch E; Laubscher R; Parker MI
Int J Cancer; 2003 Oct; 107(1):38-45. PubMed ID: 12925954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
